Abstract
Purpose
To estimate the clinical characteristics of retinal arterial macroaneurysms (RAM) and evaluate the prognosis of different interventions.
Methods
This study is a meta-analysis. The databases PubMed, EMBASE, and Ovid from inception to January 2021 were searched to identify the relevant studies. R software version 3.6.3 was used to perform the statistical analyses. Results in proportion with 95% confidence interval were calculated by means of Freeman-Tukey variant of arcsine square transformation.
Results
Sixty-nine studies involving 1332 patients were finally included. The pooling results indicated that 91% (95% CI [88 ~ 94%]) of the RAM patients were over sixty, 73% (95% CI [68 ~ 77%]) were female, and 73% (95% CI [66 ~ 79%]) have hypertension. By observation, the RAM closure rate was 64% (95% CI [39 ~ 86%]), the visual acuity (VA) improved in 55% (95% CI [40 ~ 71%]) of the patients, and the VA of 64% (95% CI [54 ~ 74%]) hemorrhagic versus 27% (95% CI [15 ~ 41%]) exudative patients improved significantly. By laser, the closure rate was 96% (95% CI [87 ~ 100%]), the VA improved in 73% (95% CI [65 ~ 80%]) of the patients, and the VA of 66% (95% CI [47 ~ 84%]) hemorrhagic versus 35% (95% CI [23 ~ 47%]) exudative patients improved significantly. By anti-VEGF, the closure rate was 98% (95% CI [93 ~ 100%]), the VA improved in 90% (95% CI [74 ~ 100%]) of the patients, and the VA of 58% (95% CI [18 ~ 94%]) hemorrhagic versus 67% (95% CI [31 ~ 96%]) exudative patients improved significantly.
Conclusion
RAM are most commonly seen in the elderly with a marked female predominance and a strong association with hypertension. Patients receiving laser or anti-VEGF treatments get higher closure rate and better visual prognosis than those with observation alone. Hemorrhagic RAM have a better visual prognosis by observation or laser treatment, while exudative RAM have a better visual prognosis by anti-VEGF treatment.
Similar content being viewed by others
Availability of data and material
The datasets presented in this study are available from the corresponding author upon request.
Code availability
Not applicable.
Abbreviations
- RAM:
-
Retinal arterial macroaneurysms
- VEGF:
-
Vascular endothelial growth factor
- ST:
-
Superotemporal
- IT:
-
Inferotemporal
- SILMH:
-
Subinternal limiting membrane hemorrhage
- IRH:
-
Intraretinal hemorrhage
- SRH:
-
Subretinal hemorrhage
- VA:
-
Visual acuity
- PPV:
-
Pars plana vitrectomy
- YAG:
-
Yttrium aluminum garnet
- tPA:
-
Tissue plasminogen activator
References
Robertson DM (1973) Macroaneurysms of the retinal arteries. Trans Am Acad Ophthalmol Otolaryngol 77(1):OP55-67
Xu L, Wang Y, Jonas JB (2007) Frequency of retinal macroaneurysms in adult Chinese: the Beijing Eye Study. Br J Ophthalmol 91(6):840–841
Nangia V, Jonas JB, Khare A, Sinha A, Lambat S (2013) Prevalence of retinal macroaneurysms. The Central India Eye and Medical Study. Acta Ophthalmol 91(2):e166-167
Lavin MJ, Marsh RJ, Peart S, Rehman A (1987) Retinal arterial macroaneurysms: a retrospective study of 40 patients. Br J Ophthalmol 71(11):817–825
Pitkänen L, Tommila P, Kaarniranta K, Jääskeläinen JE, Kinnunen K (2014) Retinal arterial macroaneurysms. Acta Ophthalmol 92(2):101–104
Mansour AM, Foster RE, Gallego-Pinazo R, Moschos MM, Sisk RA, Chhablani J, Rojanaporn D, Sujirakul T, Arevalo JF, Lima LH, Wu L, Charbaji A, Saatci AO, Mansour HA, Martinez-Rubio C, Patel Y, Gangakhedkar S (2019) Intravitreal anti-vascular endothelial growth factor injections for exudative retinal arterial macroaneurysms. Retina (Philadelphia, Pa) 39(6):1133–1141
Pichi F, Morara M, Torrazza C, Manzi G, Alkabes M, Balducci N, Vitale L, Lembo A, Ciardella AP, Nucci P (2013) Intravitreal bevacizumab for macular complications from retinal arterial macroaneurysms. Am J Ophthalmol 155(2):287-294.e281
Humayun M, Lewis H, Flynn HW Jr, Sternberg P Jr, Blumenkranz MS (1998) Management of submacular hemorrhage associated with retinal arterial macroaneurysms. Am J Ophthalmol 126(3):358–361
Wu TT, Sheu SJ (2005) Intravitreal tissue plasminogen activator and pneumatic displacement of submacular hemorrhage secondary to retinal artery macroaneurysm. J Ocul Pharmacol Ther 21(1):62–67
Maltsev DS, Kulikov AN, Uplanchiwar B, Lima LH, Chhablani J (2018) Direct navigated laser photocoagulation as primary treatment for retinal arterial macroaneurysms. Int J Retina Vitreous 4:28
Nakamura H, Hayakawa K, Sawaguchi S, Gaja T, Nagamine N, Medoruma K (2008) Visual outcome after vitreous, sub-internal limiting membrane, and/or submacular hemorrhage removal associated with ruptured retinal arterial macroaneurysms. Graefes Arch Clin Exp Ophthalmol 246(5):661–669
Meyer JC, Ahmad BU, Blinder KJ, Shah GK (2015) Laser therapy versus observation for symptomatic retinal artery macroaneurysms. Graefes Arch Clin Exp Ophthalmol 253(4):537–541
Cho WH, Chiang WY, Chen CH, Kuo HK (2020) To treat or not to treat: a clinical series of retinal arterial macroaneurysms: a single-center retrospective study. Medicine (Baltimore) 99(5):e19077
Chen YY, Lin LY, Chang PY, Chen FT, Mai ELC, Wang JK (2017) Laser and anti-vascular endothelial growth factor agent treatments for retinal arterial macroaneurysm. Asia Pac J Ophthalmol (Phila) 6(5):444–449
Cahuzac A, Scemama C, Mauget-Faÿsse M, Sahel JA, Wolff B (2016) Retinal arterial macroaneurysms: clinical, angiographic, and tomographic description and therapeutic management of a series of 14 cases. Eur J Ophthalmol 26(1):36–43
Chatziralli I, Maniatea A, Koubouni K, Parikakis E, Mitropoulos P (2017) Intravitreal ranibizumab for retinal arterial macroaneurysm: long-term results of a prospective study. Eur J Ophthalmol 27(2):215–219
Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol 62(10):1006–1012
Moosavi RA, Fong KC, Chopdar A (2006) Retinal artery macroaneurysms: clinical and fluorescein angiographic features in 34 patients. Eye (Lond) 20(9):1011–1020
Speilburg AM, Klemencic SA (2014) Ruptured retinal arterial macroaneurysm: diagnosis and management. J Optom 7(3):131–137
Panton RW, Goldberg MF, Farber MD (1990) Retinal arterial macroaneurysms: risk factors and natural history. Br J Ophthalmol 74(10):595–600
Zhao P, Hayashi H, Oshima K, Nakagawa N, Ohsato M (2000) Vitrectomy for macular hemorrhage associated with retinal arterial macroaneurysm. Ophthalmology 107(3):613–617
Iijima H, Satoh S, Tsukahara S (1998) Nd:YAG laser photodisruption for preretinal hemorrhage due to retinal macroaneurysm. Retina (Philadelphia, Pa) 18(5):430–434
Brown DM, Sobol WM, Folk JC, Weingeist TA (1994) Retinal arteriolar macroaneurysms: long-term visual outcome. Br J Ophthalmol 78(7):534–538
Cleary PE, Kohner EM, Hamilton AM, Bird AC (1975) Retinal macroaneurysms. Br J Ophthalmol 59(7):355–361
Abdel-Khalek MN, Richardson J (1986) Retinal macroaneurysm: natural history and guidelines for treatment. Br J Ophthalmol 70(1):2–11
Kester E, Walker E (2009) Retinal arterial macroaneurysm causing multilevel retinal hemorrhage. Optometry 80(8):425–430
Rabb MF, Gagliano DA, Teske MP (1988) Retinal arterial macroaneurysms. Surv Ophthalmol 33(2):73–96
Yang CS, Tsai DC, Lee FL, Hsu WM (2005) Retinal arterial macroaneurysms: risk factors of poor visual outcome. Ophthalmologica 219(6):366–372
Koinzer S, Heckmann J, Tode J, Roider J (2015) Long-term, therapy-related visual outcome of 49 cases with retinal arterial macroaneurysm: a case series and literature review. Br J Ophthalmol 99(10):1345–1353
Parodi MB, Iacono P, Ravalico G, Bandello F (2011) Subthreshold laser treatment for retinal arterial macroaneurysm. Br J Ophthalmol 95(4):534–538
Zweifel SA, Töns MS, Pfenninger L, Becker M, Michels S (2013) Intravitreal anti-VEGF therapy for retinal macroaneurysm. Klin Monbl Augenheilkd 230(4):392–395
Tsakpinis D, Nasr MB, Tranos P, Krassas N, Giannopoulos T, Symeonidis C, Dimitrakos SA, Konstas AG (2011) The use of bevacizumab in a multilevel retinal hemorrhage secondary to retinal macroaneurysm: a 39-month follow-up case report. Clin Ophthalmol 5:1475–1477
Cho HJ, Rhee TK, Kim HS, Han JI, Lee DW, Cho SW, Kim JW (2013) Intravitreal bevacizumab for symptomatic retinal arterial macroaneurysm. Am J Ophthalmol 155(5):898–904
Kishore K (2016) Long-term management of complications of retinal artery macroaneurysms with intravitreal aflibercept injection. Case Rep Ophthalmol 7(3):162–171
Lee EK, Woo SJ, Ahn J, Park KH (2011) Morphologic characteristics of retinal arterial macroaneurysm and its regression pattern on spectral-domain optical coherence tomography. Retina (Philadelphia, Pa) 31(10):2095–2101
Inoue M, Shiraga F, Shirakata Y, Morizane Y, Kimura S, Hirakata A (2015) Subretinal injection of recombinant tissue plasminogen activator for submacular hemorrhage associated with ruptured retinal arterial macroaneurysm. Graefes Arch Clin Exp Ophthalmol 253(10):1663–1669
van Zeeburg EJ, Cereda MG, van Meurs JC (2013) Recombinant tissue plasminogen activator, vitrectomy, and gas for recent submacular hemorrhage displacement due to retinal macroaneurysm. Graefes Arch Clin Exp Ophthalmol 251(3):733–740
Funding
This work is supported by the Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences (2018PT32029).
Author information
Authors and Affiliations
Contributions
He Chen carried out the literature search and data extraction, and drafted the manuscript. Xin-yu Zhao devised this study and contributed to statistical analysis and revision of the manuscript. You-xin Chen coordinated and participated in the entire process of drafting and revised the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Ethics approval
Not applicable.
Consent to participate
Not applicable.
Consent for publication
Not applicable.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figure ownership
All figures submitted are owned solely by the corresponding author.
Rights and permissions
About this article
Cite this article
Chen, H., Zhao, Xy., Meng, Lh. et al. Clinical characteristics of retinal arterial macroaneurysms and prognosis of different interventions. Graefes Arch Clin Exp Ophthalmol 260, 439–450 (2022). https://doi.org/10.1007/s00417-021-05364-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-021-05364-0